Immunovant Inc (IMVT)
26.54
+0.37
(+1.41%)
USD |
NASDAQ |
Nov 21, 16:00
26.54
0.00 (0.00%)
After-Hours: 20:00
Immunovant Total Assets (Quarterly): 515.71M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 515.71M |
| June 30, 2024 | 589.68M |
| March 31, 2024 | 666.36M |
| December 31, 2023 | 711.45M |
| September 30, 2023 | 292.07M |
| June 30, 2023 | 351.22M |
| March 31, 2023 | 405.84M |
| December 31, 2022 | 456.24M |
| September 30, 2022 | 428.15M |
| June 30, 2022 | 458.66M |
| March 31, 2022 | 515.56M |
| December 31, 2021 | 543.18M |
| Date | Value |
|---|---|
| September 30, 2021 | 566.73M |
| June 30, 2021 | 388.03M |
| March 31, 2021 | 412.49M |
| December 31, 2020 | 433.03M |
| September 30, 2020 | 453.90M |
| June 30, 2020 | 290.29M |
| March 31, 2020 | 109.39M |
| December 31, 2019 | 126.62M |
| September 30, 2019 | 117.79M |
| June 30, 2019 | 117.42M |
| March 31, 2019 | 0.3246M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
109.39M
Minimum
Mar 2020
711.45M
Maximum
Dec 2023
435.73M
Average
443.46M
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 391.15M |
| Electromed Inc | 48.92M |
| Xtant Medical Holdings Inc | 98.88M |
| Myomo Inc | 16.31M |
| Catheter Precision Inc | 26.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.65M |
| Shareholders Equity (Quarterly) | 449.05M |